Rockwell Medical Inc RMTI
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Rockwell Medical Renews Product Purchase Agreement with aQua Dialysis
-
Rockwell Medical Signs New 3-Year Product Purchase Agreement with Heritage Dialysis
-
Rockwell Medical Announces First Quarter 2026 Results and Additional 2026 Guidance with Focus on Profitability
-
Rockwell Medical to Release First Quarter 2026 Results on Thursday, May 7, 2026
-
Rockwell Medical Announces Fourth Quarter and Full-Year 2025 Financial and Operational Results
Trading Information
- Previous Close Price
- $0.64
- Day Range
- $0.64–0.69
- 52-Week Range
- $0.60–2.10
- Bid/Ask
- $0.65 / $0.70
- Shares Outstanding
- 39.47M
- Market Cap
- $26.73M
- Volume/Avg
- 437,162 / 282,181
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.34
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, acid, and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate, among others. The company delivers the majority of its hemodialysis concentrates products and mixers to dialysis clinics throughout the United States and internationally, utilizing its own delivery trucks and third-party carriers.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 157
- Website
- https://www.rockwellmed.com
Valuation
|
Metric
|
RMTI
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.69 |
Price/Sales | 0.34 |
Price/Cash Flow | 31.24 |
Price/Earnings
RMTI
Financial Strength
|
Metric
|
RMTI
|
|---|---|
Quick Ratio | 3.32 |
Current Ratio | 3.74 |
Interest Coverage | −3.97 |
Quick Ratio
RMTI
Profitability
|
Metric
|
RMTI
|
|---|---|
Return on Assets (Normalized) | −6.65% |
Return on Equity (Normalized) | −10.78% |
Return on Invested Capital (Normalized) | −5.82% |
Return on Assets
RMTI
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| Wkcczjvfs | Srgzc | $67B | |||
| Teva Pharmaceutical Industries Ltd ADR
TEVA
| Kwpkrmxmq | Shjgbf | $40B | |||
| Haleon PLC ADR
HLN
| Mwcvdwdgk | Wjg | $40B | |||
| Zoetis Inc Class A
ZTS
| Qwxtlmhxx | Qyp | $33B | |||
| Viatris Inc
VTRS
| Ghtpnzw | Cmpy | $19B | |||
| Elanco Animal Health Inc
ELAN
| Pcvk | Ycjnf | $12B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Wkrqcdds | Vykc | $11B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| Dpmzhyzkk | Dtrr | $6B | |||
| Prestige Consumer Healthcare Inc
PBH
| Psshswbzd | Nbfqlj | $2B | |||
| Perrigo Co PLC
PRGO
| Hlrvxpx | Ykl | $2B |
United States